Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8486
Reference
MSAN(2025)31
Name
Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour, 70micrograms/hour transdermal patches; Buprenorphine (Bupeaze®) 52.5micrograms/hour transdermal patches
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Health Boards
Special Health Boards
Serious Shortage Protocols
Description
Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour and 70micrograms/hour transdermal patches are out of stock until early August 2025. Buprenorphine (Bupeaze®) 52.5micrograms/hour transdermal patches are out of stock until early October 2025.
Relevtec® and Bupeaze® are matrix formulation 4-day (96-hourly) transdermal patches.
Alternative buprenorphine matrix formulation 4-day (96-hourly) patches remain available (Bupeaze® [35micrograms/hour and 70micrograms/hour strengths remain available], Carlosafine®, and Transtec®) and can support increased demand.
Contact Name
Contact Email
Contact Address
Created
2025-06-25 12:17:00
Click to go back to homepage